About
Self-Replicating RNA
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyChina
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
919
By Phase
PHASE1: 6PHASE2: 1
By Status
ACTIVE_NOT_RECRUITING: 2COMPLETED: 2UNKNOWN: 2NOT_YET_RECRUITING: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06781125Lead Sponsor
One Trial of JCXH-211 Intratumoral Injection Combined With Anti-PD-1 Antibody in Patients With Malignant Solid Tumors
PHASE1Not yet recruiting
72 participants
Started: Feb 10, 2025 · Completed: Jun 30, 2028
NCT06581575Lead Sponsor
A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine
PHASE2Active, not recruiting
467 participants
Started: Oct 16, 2024 · Completed: Aug 31, 2025
NCT06564194Lead Sponsor
A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV
PHASE1Active, not recruiting
75 participants
Started: Sep 25, 2024 · Completed: Jun 30, 2025
NCT05871541Lead Sponsor
A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine
PHASE1Completed
75 participants
Started: May 26, 2023 · Completed: Mar 25, 2024
NCT05743335Lead Sponsor
A Phase 1 Study to Assess the Safety and Immunogenicity of JCXH-221, an MRNA-based Broadly Protective COVID-19 Vaccine
PHASE1Completed
73 participants
Started: Mar 7, 2023 · Completed: Dec 1, 2023
Locations (1)
Headquarters
Shanghai, China
Map
Loading map...